Table of Contents
Expected Upcoming Milestones for Our Oncology/Hematology Companies Under Coverage .... 1
Expected Upcoming Milestones for Our Cardiovascular Companies Under Coverage ................... 3
Recent and Upcoming Scientific/Medical Conferences .................................................................. 4
Investment Risks ............................................................................................................................ 6
Companies Under Coverage in the Oncology/Hematology Space
Alexion Pharmaceuticals .................................................................................................................. 7
Allos Therapeutics ........................................................................................................................... 9
AMAG Pharmaceuticals .................................................................................................................. 11
Antisoma ……………….................................................................................................................. 13
ArQule ………………..................................................................................................................... 15
Celldex Therapeutics ……………….. ............................................................................................. 17
Dendreon ……………….. .............................................................................................................. 19
Geron …………………................................................................................................................... 21
Poniard Pharmaceuticals ................................................................................................................. 23
Regeneron Pharmaceuticals.............................................................................................................. 25
Seattle Genetics ………………......................................................................................................... 27
Telik …………………….. ................................................................................................................ 29
Companies Under Coverage in the Cardiovascular Disease Space
Cytokinetics ……………….. ............................................................................................................ 31
Dyax ……………….. ....................................................................................................................... 33
Isis Pharmaceuticals ………………………………..………………..………………..………………... 35